Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11149-11156

  Li, Jia ^a   Chen, Weian ^a   Li, Yu'an ^a   Chen, Ying ^a   Ding, Zhangna ^a   Yang, Dehao ^a   Zhang, Xu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell transplantation; Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis (MS); Olfactory ensheathing cells (OECs)

Indexed keywords

BIOLOGICAL MARKER; FREUND ADJUVANT; GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, RAT; PERTUSSIS TOXIN;

ANIMAL; BRAIN; CELL CULTURE; CELL TRANSPLANTATION; COMPARATIVE STUDY; CONVALESCENCE; CYTOLOGY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIA; GUINEA PIG; IMMUNOLOGY; LEWIS RAT; METABOLISM; NEUROLOGIC EXAMINATION; OLFACTORY NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; SPINAL CORD; SPRAGUE DAWLEY RAT; TIME FACTOR; TRANSPLANTATION; XENOGRAFT;

ANIMALS; BIOMARKERS; BRAIN; CELL TRANSPLANTATION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FREUND'S ADJUVANT; GUINEA PIGS; HETEROGRAFTS; NERVE TISSUE PROTEINS; NEUROGLIA; NEUROLOGIC EXAMINATION; OLFACTORY NERVE; PERTUSSIS TOXIN; PHENOTYPE; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RECEPTORS, GROWTH FACTOR; RECOVERY OF FUNCTION; SPINAL CORD; TIME FACTORS;

EID: 85013040644     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Caggiula M, Mirabella M, Tonali PA and Batocchi AP. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Cytokine 2008; 44: 22-25.
2. Duffy SS, Lees JG and Moalem-Taylor G. The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Mult Scler Int 2014; 2014: 285245.
3. Stangel M and Hartung HP. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 2002; 68: 361-376.
4. Noseworthy JH, Lucchinetti C, Rodriguez M and Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-952.
5. Pryce G and Baker D. Emerging properties of cannabinoid medicines in management of multiple sclerosis. Trends Neurosci 2005; 28: 272-276.
6. Berger T, Weerth S, Kojima K, Linington C, Wekerle H and Lassmann H. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997; 76: 355-364.
7. Gold R, Hartung HP and Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000; 6: 88-91.
8. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF and Bernard CC. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 1995; 154: 5536-5541.
9. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, Olsson T, Linington C and Lassmann H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8: 681-694.
10. Lu J, Feron F, Ho SM, Mackay-Sim A and Waite PM. Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res 2001; 889: 344-357.
11. Aharoni R. Immunomodulation neuroprotection and remyelination-the fundamental therapeutic effects of glatiramer acetate: a critical review. J Autoimmun 2014; 54: 81-92.
12. Ellwardt E and Zipp F. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS. Exp Neurol 2014; 262 Pt A: 8-17.
13. Lassmann H. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility. J Neurol Sci 2005; 233: 83-86.
14. Pluchino S and Martino G. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J Neurol Sci 2005; 233: 117-119.
15. Doucette JR. The glial cells in the nerve fiber layer of the rat olfactory bulb. Anat Rec 1984; 210: 385-391.
16. Doucette R. PNS-CNS transitional zone of the first cranial nerve. J Comp Neurol 1991; 312: 451-466.
17. Doucette R. Glial influences on axonal growth in the primary olfactory system. Glia 1990; 3: 433-449.
18. Devon R and Doucette R. Olfactory ensheathing cells myelinate dorsal root ganglion neurites. Brain Res 1992; 589: 175-179.
19. Ramon-Cueto A and Nieto-Sampedro M. Glial cells from adult rat olfactory bulb: immunocytochemical properties of pure cultures of ensheathing cells. Neuroscience 1992; 47: 213-220.
20. Goodman MN, Silver J and Jacobberger JW. Establishment and neurite outgrowth properties of neonatal and adult rat olfactory bulb glial cell lines. Brain Res 1993; 619: 199-213.
21. Miragall F, Kadmon G and Schachner M. Expression of L1 and N-CAM cell adhesion molecules during development of the mouse olfactory system. Dev Biol 1989; 135: 272-286.
22. Scotti AL, Hoffmann MC and Nitsch C. The neurite growth promoting protease nexin 1 in glial cells of the olfactory bulb of the gerbil: an ultrastructural study. Cell Tissue Res 1994; 278: 409-413.
23. Ubink R, Halasz N, Zhang X, Dagerlind A and Hökfelt T. Neuropeptide tyrosine is expressed in ensheathing cells around the olfactory nerves in the rat olfactory bulb. Neuroscience 1994; 60: 709-726.
24. Ramon-Cueto A and Valverde F. Olfactory bulb ensheathing glia: a unique cell type with axonal growth-promoting properties. Glia 1995; 14: 163-173.
25. Nash HH, Borke RC and Anders JJ. New method of purification for establishing primary cultures of ensheathing cells from the adult olfactory bulb. Glia 2001; 34: 81-87.
26. Li J and Zhang X. The purification methods of olfactory ensheathing cells for transplantation. Chin J Neuroimmunol Neurol 2008; 16: 325-329.
27. Kono DH, Urban JL, Horvath SJ, Ando DG, Saavedra RA and Hood L. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J Exp Med 1988; 168: 213-227.
28. Brambilla R, Morton PD, Ashbaugh JJ, Karmally S, Lambertsen KL and Bethea JR. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia 2014; 62: 452-467.
29. Olsen JA and Akirav EM. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. J Neurosci Res 2015; 93: 687-696.
30. Wingerchuk DM. Current evidence and therapeutic strategies for multiple sclerosis. Semin Neurol 2008; 28: 56-68.
31. Payne N, Siatskas C and Bernard CC. The promise of stem cell and regenerative therapies for multiple sclerosis. J Autoimmun 2008; 31: 288-294.
32. Wang H, Munger KL, Reindl M, O'Reilly EJ, Levin LI, Berger T and Ascherio A. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 2008; 71: 1142-1146.
33. Duncan ID. Replacing cells in multiple sclerosis. J Neurol Sci 2008; 265: 89-92.
34. Ramon-Cueto A. Olfactory ensheathing glia transplantation into the injured spinal cord. Prog Brain Res 2000; 128: 265-272.
35. Ramon-Cueto A and Nieto-Sampedro M. Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp Neurol 1994; 127: 232-244.